🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

ICU Medical CEO Vivek Jain sells shares worth $1.95 million

Published 12/03/2024, 10:14 AM
ICUI
-

Vivek Jain, the Chairman and CEO of ICU Medical Inc. (NASDAQ:ICUI), has sold shares in the company totaling approximately $1.95 million, according to a recent SEC filing. The transactions occurred on December 2, 2024, and involved the disposal of 12,000 shares at prices ranging from $162.29 to $163.96 per share. The $3.96 billion market cap company has shown strong momentum, delivering a 76% return over the past year. According to InvestingPro analysis, the stock currently trades near its Fair Value.

In addition to the sales, Jain also exercised options to acquire 12,000 shares of common stock at a price of $88.76 per share, valued at approximately $1.07 million. Following these transactions, Jain's direct ownership in ICU Medical (TASE:PMCN) stands at 104,593 shares. The sales were executed under a Rule 10b5-1 trading plan that Jain adopted in March 2024. With analyst targets ranging from $178 to $225 and an overall "Good" financial health score from InvestingPro, investors can access detailed insights and 10 additional ProTips through the platform's comprehensive research reports.

In other recent news, ICU Medical Inc. reported a revenue of $580 million in the third quarter of 2024, marking a 7% increase on a constant currency basis. The company's adjusted EBITDA stood at $95 million, with gross margins improving due to supply chain efficiencies. ICU Medical also announced a strategic joint venture with Otsuka, aiming to enhance the company's position in the IV solutions market.

This development comes amid strong demand across all regions and growth in the company's consumables and IV systems segments. Furthermore, ICU Medical has raised its future guidance, with adjusted EBITDA expected to be between $355 million to $365 million and adjusted EPS projected at $5.40 to $5.70 per share.

Despite some disruption due to the U.S. portion of their ERP implementation, the company remains on track to complete all projects by the end of 2024. The joint venture is expected to be neutral to marginally positive for free cash flow. These are among the recent developments for ICU Medical Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.